CN108610308A - The method that one kettle way prepares Nintedanib intermediate - Google Patents

The method that one kettle way prepares Nintedanib intermediate Download PDF

Info

Publication number
CN108610308A
CN108610308A CN201611125477.8A CN201611125477A CN108610308A CN 108610308 A CN108610308 A CN 108610308A CN 201611125477 A CN201611125477 A CN 201611125477A CN 108610308 A CN108610308 A CN 108610308A
Authority
CN
China
Prior art keywords
added
methyl
reaction
hours
stirred
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611125477.8A
Other languages
Chinese (zh)
Inventor
何先亮
赵胤
张继承
黄鲁宁
陶安平
顾虹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Aobo Bio Pharmaceutical Technology Co Ltd
Original Assignee
Shanghai Aobo Bio Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Aobo Bio Pharmaceutical Technology Co Ltd filed Critical Shanghai Aobo Bio Pharmaceutical Technology Co Ltd
Priority to CN201611125477.8A priority Critical patent/CN108610308A/en
Publication of CN108610308A publication Critical patent/CN108610308A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the methods that " one kettle way " prepares Nintedanib (Nintedanib, I) key intermediate N (4 aminophenyl) N methyl 2 (4 methyl piperazine, 1 base) acetamide.Method is as follows:It is realized especially by following technical scheme:The aqueous solution that 4 nitroaniline of N methyl is dissolved in organic solvent and alkali mixes, then chloracetyl chloride or bromoacetyl bromide is added dropwise, at 0 70 degree, the progress first stage reacts 0.1 3 hours, branch vibration layer is added N methyl piperazines and carries out second stage reaction, and 0 75 degree are reacted 2 10 hours, then go back original reagent is added, 0 75 degree, pressure 15 100psi progress phase III reactions, 8 36 hours.Filtering removal go back original reagent after reaction, reaction solution concentrates, reverse phase solvent crystallization is added and obtains Nintedanib (Nintedanib, I) key intermediate N (4 aminophenyl) N methyl 2 (4 methyl piperazine, 1 base) acetamide (formula B).The preparation method raw material is easy to get, and concise in technology is economic and environment-friendly, is suitble to industrialized production.

Description

The method that one kettle way prepares Nintedanib intermediate
Technical field:
The invention belongs to organic synthesis and the preparing technical field of bulk pharmaceutical chemicals intermediate, more particularly to a kind of " one kettle way " system It is ready for use on key intermediate N- (the 4- aminobenzenes of the drug Nintedanib (nintedanib, I) for the treatment of idiopathic pulmonary fibrosis Base)-N- methyl -2- (4- methylpiperazine-1-yls) acetamide (formula B) method.
Background technology:
Nintedanib (nintedanib, I) is a kind of novel for treating special hair of Boehringer Ingelheim company exploitation The oral drugs of property pulmonary fibrosis.Idiopathic pulmonary fibrosis is a kind of to the serious lethal lung disease of mankind's harm, patient Median survival interval after diagnosis is only 2 to 3 years.Nintedanib can vegf blocker receptor, blood be small simultaneously Plate source property growth factor receptors and fibroblast growth factor acceptor.The blocking of these receptors can lead to the suppression of angiogenesis System.Nintedanib is first and only one is approved the tyrosine kinase inhibitor for treating idiopathic pulmonary fibrosis.
The chemistry of Nintedanib is entitled:Z- [1- (4- (N- ((4- thyl-piperazin -1- bases)-methyl carbonyl)-N- methyl-ammonia Base)-anilino-) -1- phenyi-methylenes] -2- oxo -2,3- dihydro -1H- indoles 6- methyl formates, structural formula is as follows (I):
The preparation method of Nintedanib is it has been reported that original grinds compound patent WO2001027081 and prepares patent WO2009071523, WO 2009071524 gives the synthetic method of Nintedanib and the like.Its main synthesis side Method is condensed to yield by two key intermediates A and B in following formula.
Patent CN104262232A reports another synthetic method of Nintedanib, but is equally used in committed step Key intermediate B.Therefore intermediate B is a necessary key intermediate in Nintedanib industrialization, therefore among this The industrialization research of body has great realistic meaning.
But pass through investigation, it has been found that relatively fewer, main source is reported for the main synthetic route of the intermediate In the preparation patent that original is ground, specifically prepared through following formula method:
Use B-1 (N- methyl-4-nitrophenylamines) for starting material, by with chloracetyl chloride or bromoacetyl bromide alkali work Amidation process is first carried out with lower, substitution reaction then occurs with methyl piperazine, finally obtains intermediate B by reduction;Due to In original grinds technique, which often walks reaction and substep is required for carry out, and intermediate is required for Crystallization Separation, entire process cycle It is long, and mixed solvent is often used in crystallization process, cause solvent recovery difficulty big, route yield is low, not green.Therefore anxious Simplification of flowsheet is needed, three waste discharge is reduced so that entire technique is more green, more economically, is more applicable in industrial metaplasia Production.
Invention content:
For current present situation, the present invention is realized using craftsmenship using single organic solvent by the change of feed way Series connection to entire technique, " one kettle way " linearly synthesize Nintedanib (Nintedanib, I) key intermediate B, i.e. N- (4- ammonia Base phenyl)-N- methyl -2- (4- methylpiperazine-1-yls) acetamide.The preparation method concise in technology, the period is short, more economically, It is more environmentally-friendly, it is suitble to industrialized production.
It is realized especially by following technical scheme:N- methyl-4-nitrophenylamines are dissolved in the water of organic solvent and alkali Solution mixes, and chloracetyl chloride or bromoacetyl bromide is then added dropwise, and carries out first stage reaction 0.1-3 hours in 0-75 degree, divides and go Water layer is added N methyl piperazine and carries out second stage reaction, and 0-75 degree reacts 2-10 hours, and go back original reagent, 0-75 is then added Degree, pressure 15-100psi progress phase III reactions, 8-36 hours.Filtering removal go back original reagent, reaction solution are dense after reaction Contracting is added reverse phase solvent crystallization and obtains Nintedanib (Nintedanib, I) key intermediate B
The wherein described organic solvent includes ethyl acetate, dichloromethane, isopropyl acetate, toluene, tetrahydrofuran and 2- first Base tetrahydrofuran.Reverse phase solvent includes normal heptane, n-hexane, hexamethylene, methyl tertiary butyl ether(MTBE).
The wherein described alkali includes sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, bicarbonate Sodium, saleratus;
The wherein described go back original reagent includes:Hydrogen, palladium/carbon, platinum/charcoal, Raney's nickel.
Wherein main three kinds of reaction reagents N- methyl-4-nitrophenylamines, chloracetyl chloride or bromoacetyl bromide and N- methyl piperazines The molar ratio of piperazine is 1:1.5~3:1.5~3, base amount is 1-3 times of key reaction reagent chloracetyl chloride or bromoacetyl bromide
The reaction principle be first stage N- methyl-4-nitrophenylamine in the presence of alkali with chloracetyl chloride or bromoacetyl bromide Amidation process occurs, substitution reaction occurs with N methyl piperazine again for the chlorine or bromine substituent group on α carbon of second stage amide, the Three stages were that nitro substituent is reduced to aniline by reducing agent on phenyl ring.
Reaction is by following course (alkali is by taking sodium carbonate is alkali as an example):
The chloracetic acid and hydrochloric acid that side reaction generates in reaction process in the first stage are dissolved at salt in the presence of alkali In water phase, and product is maintained at organic phase, the influence for dividing water layer that can remove reaction of these by-products to second stage well. Excessive N methyl piperazine can be with the hydrochloric acid that generates during the reaction at salt during second stage, and these salt will not be to Triphasic reduction reaction impacts, and salt is not dissolved in organic solvent, can be together with reduction after reduction reaction Reagent filtering removal, by concentration be added reverse phase solvent crystallization can high yield obtain Nintedanib key intermediate B (N- (4- aminophenyls)-N- methyl -2- (4- methylpiperazine-1-yls) acetamide), and then eliminated well in mother liquor it is excessive not At the N methyl piperazine and some related impurities of salt, 97% or more product purity is obtained, total recovery is 85% or more.
Compared to prior art, the method for " one kettle way " according to the present invention preparation Nintedanib (I) key intermediate B Have many advantages, such as concise in technology, it is economic and environment-friendly, it is suitble to industrialized production.
Embodiment:
Unrestricted illustrate is carried out to technical scheme of the present invention below by way of several specific embodiments.Wherein, Raw material N- methyl-4-nitrophenylamines, chloracetyl chloride, bromoacetyl bromide and N methyl piperazine can bulk purchases.
Embodiment 1:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 18.2g potassium carbonate and 55mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g Pd/C, hydrogen displacement adjustment pressure is then added 40-45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, and filter to obtain production Product, yield 91.5%.1H NMR(400MHz,CDCl3):δ 6.88 (d, J=8.4,2H), 6.54 (d, J=8.4,2H), δ 5.22 (s, 2H), 3.03 (s, 3H), 2.35~2.27 (M, 4H), 2.27~2.19 (m, 4H), 2.10 (s, 3H) Mass:263.2[M+H+]。
Embodiment 2:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 150mL ethyl acetate, 18.2g potassium carbonate with And 55mL water, 20-25 DEG C of temperature is adjusted, 12.5g chloracetyl chlorides are added dropwise in reaction bulb, 20-25 DEG C is stirred 0.5 hour, point Water layer is removed, 15.8gN- methyl piperazines are added, 20-25 DEG C is stirred 5 hours, and 0.5g Pd/C, hydrogen displacement adjustment pressure is then added Power 40-45psi, 40-55 DEG C is stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, filter Product, yield 92.3%.
Embodiment 3
10g N- methyl-4-nitrophenylamines, 150mL isopropyl acetates, 18.2g potassium carbonate are added in 250mL reaction bulbs And 55mL water, 20-25 DEG C of temperature is adjusted, 12.5g chloracetyl chlorides are added dropwise in reaction bulb, 20-25 DEG C is stirred 0.5 hour, 15.8gN- methyl piperazines are added in branch vibration layer, and 20-25 DEG C is stirred 5 hours, and 0.5g Pd/C, hydrogen displacement adjustment is then added Pressure 40-45psi, 40-55 DEG C is stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes, filtering is added Obtain product, yield 90.4%.
Embodiment 4:
10g N- methyl-4-nitrophenylamines, 100mL2- methyltetrahydrofurans, 18.2g carbon are added in 250mL reaction bulbs Sour potassium and 55mL water adjust 20-25 DEG C of temperature, 12.5g chloracetyl chlorides are added dropwise in reaction bulb, and 20-25 DEG C of stirring 0.5 is small When, 15.8gN- methyl piperazines are added in branch vibration layer, and 20-25 DEG C is stirred 5 hours, and 0.5g Pd/C are then added, and hydrogen displacement is adjusted Seamless power 40-45psi, 40-55 DEG C is stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes, mistake is added Filter to obtain product, yield 86.4%.
Embodiment 5:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 100mL tetrahydrofurans, 18.2g potassium carbonate with And 55mL water, 20-25 DEG C of temperature is adjusted, 12.5g chloracetyl chlorides are added dropwise in reaction bulb, 20-25 DEG C is stirred 0.5 hour, point Water layer is removed, 15.8gN- methyl piperazines are added, 20-25 DEG C is stirred 5 hours, and 0.5g Pd/C, hydrogen displacement adjustment pressure is then added Power 40-45psi, 40-55 DEG C is stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, filter Product, yield 89.7%.
Embodiment 6:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 150mL toluene, 18.2g potassium carbonate and 55mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g Pd/C, hydrogen displacement adjustment pressure is then added 40-45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, and filter to obtain production Product, yield 86.9%.
Embodiment 7:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 18.2g potassium carbonate and 55mL water adjusts 20-25 DEG C of temperature, 22.4g bromoacetyl bromides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g Pd/C, hydrogen displacement adjustment pressure is then added 40-45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, and filter to obtain production Product, yield 90.1%.
Embodiment 8:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 18.2g potassium carbonate and 55mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g platinum/carbon, hydrogen displacement adjustment pressure is then added 40-45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, and filter to obtain production Product, yield 90.7%.
Embodiment 9:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 18.2g potassium carbonate and 55mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g Raney's nickels, hydrogen displacement adjustment pressure is then added 40-45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, and filter to obtain production Product, yield 90.3%.
Embodiment 10:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 18.2g potassium carbonate and 55mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g palladium dydroxides, hydrogen displacement adjustment pressure is then added Power 40-45psi, 40-55 DEG C is stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, filter Product, yield 90.3%.
Embodiment 11:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 100mL ethyl acetate, 18.2g potassium carbonate with And 55mL water, 0 DEG C of temperature is adjusted, 12.5g chloracetyl chlorides are added dropwise in reaction bulb, 20-25 DEG C is stirred 0.5 hour, is divided and is removed water 15.8gN- methyl piperazines are added in layer, and 0-5 DEG C is stirred 10 hours, and 0.5g Pd/C, hydrogen displacement adjustment pressure 40- is then added 45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, filter to obtain product, Yield 88.3%.
Embodiment 12:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 100mL ethyl acetate, 18.2g potassium carbonate with And 55mL water, temperature 70 C is adjusted, 12.5g chloracetyl chlorides are added dropwise in reaction bulb, 70-75 DEG C is stirred 0.5 hour, is divided and is removed water 15.8gN- methyl piperazines are added in layer, and 70-75 DEG C is stirred 2 hours, and 0.5g Pd/C, hydrogen displacement adjustment pressure 40- is then added 45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, filter to obtain product, Yield 86.3%.
Embodiment 13:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 14.0g sodium carbonate and 55mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g palladiums/carbon, hydrogen displacement adjustment pressure is then added 40-45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, and filter to obtain production Product, yield 91.3%.
Embodiment 14:Nintedanib (I)
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 10.5g sodium hydroxides with And 100mL water, 20-25 DEG C of temperature is adjusted, 12.5g chloracetyl chlorides are added dropwise in reaction bulb, 20-25 DEG C is stirred 0.5 hour, point Water layer is removed, 15.8gN- methyl piperazines are added, 20-25 DEG C is stirred 5 hours, and 0.5g palladiums/carbon, hydrogen displacement adjustment pressure is then added Power 40-45psi, 40-55 DEG C is stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, filter Product, yield 88.7%.
Embodiment 15:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 14.7g potassium hydroxide with And 100mL water, 20-25 DEG C of temperature is adjusted, 12.5g chloracetyl chlorides are added dropwise in reaction bulb, 20-25 DEG C is stirred 0.5 hour, point Water layer is removed, 15.8gN- methyl piperazines are added, 20-25 DEG C is stirred 5 hours, and 0.5g palladiums/carbon, hydrogen displacement adjustment pressure is then added Power 40-45psi, 40-55 DEG C is stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, filter Product, yield 86.9%.
Embodiment 16:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 29.4g sodium bicarbonates with And 150mL water, 20-25 DEG C of temperature is adjusted, 12.5g chloracetyl chlorides are added dropwise in reaction bulb, 20-25 DEG C is stirred 0.5 hour, point Water layer is removed, 15.8gN- methyl piperazines are added, 20-25 DEG C is stirred 5 hours, and 0.5g palladiums/carbon, hydrogen displacement adjustment pressure is then added Power 40-45psi, 40-55 DEG C is stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, filter Product, yield 89.9%.
Embodiment 17:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 35g saleratus and 150mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g palladiums/carbon, hydrogen displacement adjustment pressure is then added 40-45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, and filter to obtain production Product, yield 88.1%.
Embodiment 18:
In 500mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 38.4g lithium hydroxides with And 150mL water, 20-25 DEG C of temperature is adjusted, 12.5g chloracetyl chlorides are added dropwise in reaction bulb, 20-25 DEG C is stirred 0.5 hour, point Water layer is removed, 15.8gN- methyl piperazines are added, 20-25 DEG C is stirred 5 hours, and 0.5g palladiums/carbon, hydrogen displacement adjustment pressure is then added Power 40-45psi, 40-55 DEG C is stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, filter Product, yield 90.9%.
Embodiment 19:
In 500mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 113.5g cesium carbonates with And 200mL water, 20-25 DEG C of temperature is adjusted, 12.5g chloracetyl chlorides are added dropwise in reaction bulb, 20-25 DEG C is stirred 0.5 hour, point Water layer is removed, 15.8gN- methyl piperazines are added, 20-25 DEG C is stirred 5 hours, and 0.5g palladiums/carbon, hydrogen displacement adjustment pressure is then added Power 40-45psi, 40-55 DEG C is stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, filter Product, yield 85.7%.
Embodiment 20:
In 500mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 113.5g sodium carbonate with And 200mL water, 20-25 DEG C of temperature is adjusted, 8.8g chloracetyl chlorides are added dropwise in reaction bulb, 20-25 DEG C is stirred 0.5 hour, point Water layer is removed, 15.8gN- methyl piperazines are added, 20-25 DEG C is stirred 5 hours, and 0.5g palladiums/carbon, hydrogen displacement adjustment pressure is then added Power 40-45psi, 40-55 DEG C is stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, filter Product, yield 85.1%.
Embodiment 21:
In 500mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 113.5g sodium carbonate with And 200mL water, 20-25 DEG C of temperature is adjusted, 22.1g chloracetyl chlorides are added dropwise in reaction bulb, 20-25 DEG C is stirred 0.5 hour, point Water layer is removed, 15.8gN- methyl piperazines are added, 20-25 DEG C is stirred 5 hours, and 0.5g palladiums/carbon, hydrogen displacement adjustment pressure is then added Power 40-45psi, 40-55 DEG C is stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, filter Product, yield 92.1%.
Embodiment 22:
In 500mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 15.5g potassium carbonate and 200mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g palladiums/carbon, hydrogen displacement adjustment pressure is then added 40-45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, and filter to obtain production Product, yield 86.2%.
Embodiment 23:
In 500mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 46.5g potassium carbonate and 200mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g palladiums/carbon, hydrogen displacement adjustment pressure is then added 40-45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL normal heptanes are added, and filter to obtain production Product, yield 89.8%.
Embodiment 24:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 18.2g potassium carbonate and 55mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g Pd/C, hydrogen displacement adjustment pressure is then added 40-45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL n-hexanes are added, and filter to obtain production Product, yield 90.8%.
Embodiment 25:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 18.2g potassium carbonate and 55mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g Pd/C, hydrogen displacement adjustment pressure is then added 40-45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL hexamethylenes are added, and filter to obtain production Product, yield 90.8%.
Embodiment 26:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 18.2g potassium carbonate and 55mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g Pd/C, hydrogen displacement adjustment pressure is then added 40-45psi, 40-55 DEG C are stirred 18 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL methyl tertiary butyl ether(MTBE)s, mistake is added Filter to obtain product, yield 89.8%.
Embodiment 27:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 18.2g potassium carbonate and 55mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g Pd/C, hydrogen displacement adjustment pressure is then added 15-20psi, 40-55 DEG C are stirred 36 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL methyl tertiary butyl ether(MTBE)s, mistake is added Filter to obtain product, yield 85.7%.
Embodiment 28:
In 250mL reaction bulbs be added 10g N- methyl-4-nitrophenylamines, 50mL dichloromethane, 18.2g potassium carbonate and 55mL water adjusts 20-25 DEG C of temperature, 12.5g chloracetyl chlorides is added dropwise in reaction bulb, and 20-25 DEG C is stirred 0.5 hour, is divided and is gone 15.8gN- methyl piperazines are added in water layer, and 20-25 DEG C is stirred 5 hours, and 0.5g Pd/C, hydrogen displacement adjustment pressure is then added 90-100psi, 40-55 DEG C are stirred 8 hours, and filtering, filtrate is concentrated into 1-2 times of volume, and 100mL methyl tertiary butyl ether(MTBE)s, mistake is added Filter to obtain product, yield 91.7%.

Claims (6)

1. a kind of " one kettle way " prepares Nintedanib (nintedanib, I) key intermediate N- (4- aminophenyls)-N- methyl- The method of 2- (4- methylpiperazine-1-yls) acetamide (formula B):
Step in the preparation method includes:N- methyl-4-nitrophenylamines are dissolved in the water of organic solvent and alkali by the first stage Solution mixes, and chloracetyl chloride or bromoacetyl bromide is then added dropwise, and reaction 0.1-3 hours, branch vibration layer are carried out in 0-75 degree;It is organic N methyl piperazine is added in phase and carries out second stage reaction, 0-75 degree reacts 2-10 hours, and reduction examination is directly added into reaction solution Agent, adjustment temperature 0-75 degree, reactor pressure 15-100psi progress phase III reactions, 8-36 hours.It filters after reaction Go back original reagent is removed, reaction solution concentration is added reverse phase solvent crystallization and obtains Nintedanib (Nintedanib, I) key intermediate N- (4- aminophenyls)-N- methyl -2- (4- methylpiperazine-1-yls) acetamide (formula B).
2. organic solvent described in method includes ethyl acetate, dichloromethane, isopropyl acetate, first as described in the appended claim 1 Benzene, tetrahydrofuran and 2- methyltetrahydrofurans.The reverse phase solvent includes normal heptane, n-hexane, hexamethylene, methyl tertbutyl Ether.
3. as described in the appended claim 1 in method alkali include sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, Cesium carbonate, sodium bicarbonate, saleratus.
4. go back original reagent includes described in method as described in claim 1:Hydrogen, palladium/carbon, platinum/charcoal, Raney's nickel.
5. " one kettle way " preparation method is it is characterized in that, 0-75 DEG C of first stage reaction temperature, reaction as described in the appended claim 1 Time 0.1-3 hour;0-75 DEG C of second stage reaction temperature, reaction time 3-10 hour;0-70 DEG C of phase III reaction temperature, Reaction pressure 15-100psi, reaction time 8-36 hour.
6. in " one kettle way " preparation method as described in claim 1, main material N- methyl-4-nitrophenylamines, chlorine are reacted The molar ratio of chloroacetic chloride or bromoacetyl bromide and N methyl piperazine is 1:1.5~3:1.5~3, base amount is key reaction reagent 1-3 times of chloracetyl chloride or bromoacetyl bromide.
CN201611125477.8A 2016-12-09 2016-12-09 The method that one kettle way prepares Nintedanib intermediate Pending CN108610308A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611125477.8A CN108610308A (en) 2016-12-09 2016-12-09 The method that one kettle way prepares Nintedanib intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611125477.8A CN108610308A (en) 2016-12-09 2016-12-09 The method that one kettle way prepares Nintedanib intermediate

Publications (1)

Publication Number Publication Date
CN108610308A true CN108610308A (en) 2018-10-02

Family

ID=63643332

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611125477.8A Pending CN108610308A (en) 2016-12-09 2016-12-09 The method that one kettle way prepares Nintedanib intermediate

Country Status (1)

Country Link
CN (1) CN108610308A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110746378A (en) * 2018-12-03 2020-02-04 江苏豪森药业集团有限公司 Preparation method of amino intermediate
CN115181078A (en) * 2022-07-27 2022-10-14 安徽修一制药有限公司 Synthesis method of nintedanib key intermediate

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009071524A2 (en) * 2007-12-03 2009-06-11 Boehringer Ingelheim International Gmbh Indolinone derivatives and process for their manufacture
WO2009071523A1 (en) * 2007-12-03 2009-06-11 Boehringer Ingelheim International Gmbh Process for the manufacture of an indolinone derivative
WO2012068441A2 (en) * 2010-11-19 2012-05-24 Ratiopharm Gmbh Intedanib salts and solid state forms thereof
CN104262232A (en) * 2014-09-09 2015-01-07 苏州明锐医药科技有限公司 Method for preparing nintedanib
CN104844499A (en) * 2015-06-05 2015-08-19 北京康立生医药技术开发有限公司 Synthetic method for preparing Nintedanib through one-pot process
US20150284327A1 (en) * 2014-04-04 2015-10-08 Auspex Pharmaceuticals, Inc. Oxindole inhibitors of tyrosine kinase
CN105712923A (en) * 2014-12-03 2016-06-29 江苏先声药业有限公司 Nintedanib impurity and preparation method and application thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009071524A2 (en) * 2007-12-03 2009-06-11 Boehringer Ingelheim International Gmbh Indolinone derivatives and process for their manufacture
WO2009071523A1 (en) * 2007-12-03 2009-06-11 Boehringer Ingelheim International Gmbh Process for the manufacture of an indolinone derivative
CN101883756A (en) * 2007-12-03 2010-11-10 贝林格尔.英格海姆国际有限公司 Process for the manufacture of an indolinone derivative
WO2012068441A2 (en) * 2010-11-19 2012-05-24 Ratiopharm Gmbh Intedanib salts and solid state forms thereof
US20150284327A1 (en) * 2014-04-04 2015-10-08 Auspex Pharmaceuticals, Inc. Oxindole inhibitors of tyrosine kinase
CN104262232A (en) * 2014-09-09 2015-01-07 苏州明锐医药科技有限公司 Method for preparing nintedanib
CN105712923A (en) * 2014-12-03 2016-06-29 江苏先声药业有限公司 Nintedanib impurity and preparation method and application thereof
CN104844499A (en) * 2015-06-05 2015-08-19 北京康立生医药技术开发有限公司 Synthetic method for preparing Nintedanib through one-pot process

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
GERALD J. ROTH ET AL.: "Design, Synthesis, and Evaluation of Indolinones as Triple Angiokinase Inhibitors and the Discovery of a Highly Specific 6-Methoxycarbonyl-Substituted Indolinone (BIBF 1120)", 《J.MED.CHEM.》 *
RUIXUE XU: "Design,synthesis and iological evaluation of deuterated nintedanib for improving pharmacokinetic properties", 《J.LABEL COMPD.RADIOPHAM》 *
刘薇等: "尼达尼布合成路线图解", 《中国药物化学杂志》 *
孙敏等: "抗肿瘤候选新药intedanib的合成", 《中国医药工业杂志》 *
薛永强等: "《现代有机合成方法与技术》", 31 May 2003, 化学工业出版社 *
贾本立等: "尼达尼布的合成", 《合成化学》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110746378A (en) * 2018-12-03 2020-02-04 江苏豪森药业集团有限公司 Preparation method of amino intermediate
CN110746378B (en) * 2018-12-03 2021-11-05 江苏豪森药业集团有限公司 Preparation method of amino intermediate
CN115181078A (en) * 2022-07-27 2022-10-14 安徽修一制药有限公司 Synthesis method of nintedanib key intermediate

Similar Documents

Publication Publication Date Title
CN108947891B (en) Method for safely preparing pimavanserin and tartrate thereof by using triphosgene
CN112533908B (en) Synthetic method of calicheazine
CN101863948B (en) High-purity (2 beta, 3 alpha, 5 alpha, 16 beta, 17 beta)-2-(4-morpholinyl)-16-(1-pyrrolidinyl)-androstane-3,17-diol or composition thereof and preparation method thereof
CN104356092A (en) Preparation method for vortioxetine
CN110878084A (en) Preparation method of nicosulfuron original drug
CN101993379B (en) Preparation method of cinacalcet hydrochloride
CN108610308A (en) The method that one kettle way prepares Nintedanib intermediate
CN102351778A (en) Preparation method of arbidol hydrochloride
CN103373991A (en) Method for preparing piribedil in high-purity high-yield manner
CN109485638A (en) A kind of uncommon preparation method for Buddhist nun's intermediate difficult to understand
CN105693603A (en) Improved indacaterol maleate preparation technology
CN104311467A (en) Method and device for continuous preparation of Vildagliptin by tubular reaction
CN105085290A (en) Method for synthesizing pregabalin
WO2011032476A1 (en) Method for preparing levo-betaxolol hydrochloride
CN104109135A (en) Preparation method of 1-[2-(2,4-dimethyl phenylsulfanyl)-phenyl]piperazine
CN104230909B (en) A kind of preparation method of Azilsartan
CN106349256A (en) Method for preparing cefotiam hexetil hydrochloride
CN105061234A (en) Preparation method for pregabalin
CN105061235A (en) Method for synthesizing Pregabalin
CN102491954B (en) Preparation method of linezolid
CN102199146A (en) Preparation method for N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinamine
CN101309910A (en) Process for obtaining valine derivatives useful for obtaining a pharmaceutically active compound
CN105367516A (en) Novel preparation method of vortioxetine
JP3644811B2 (en) Method for producing 4'-methyl-2-cyanobiphenyl
CN106905264B (en) A method of synthesis A Zhalawei intermediate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20181002